Enovis Corp ENOV 深 滬
等待開盤 09-17 09:30:00 美东时间
18.66
+0.720
+4.01%
華盛通- 最 高18.83
- 今 開18.09
- 成交量 101.79万股
- 最 低 17.74
- 昨 收 17.94
- 總市值 10.76亿
- 52周最高 34.28
- 市盈率 靜 --
- 換手率 1.76%
- 52周最低 17.30
- 委 比 81.07%
- 總股本 5766.95万
- 歷史最高 176.11
- 量 比 0.46
- 振 幅 6.08%
- 歷史最低 -13.31
- 每 手 1
- 風險率 3.56%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多美股周涨跌榜 | 生物医药企业SMMT周涨逾28%！关键药物取得突破；加密货币概念股齐升，IREN周内大涨26%
生物医药企业SMMT周涨逾28%！关键药物取得突破；加密货币概念股齐升，IREN周涨26%！受比特币反弹及云业务双重催化；Strive涨近25%，四天增持约1,800枚比特币>>
09-05 10:16
美股大行评级 | 最高735美元！戴尔科技绩后获11家大行上调目标价；MongoDB绩后分歧大，9家上调；4家下调；派拓网络、GitLab、美敦力获多家大行上调目标价
今日重点评级关注：Tigress Financial：维持Liftoff Mobile"买入"评级，目标价从39美元升至41美元；奥本海默：维持SpaceX"跑赢大市"评级，目标价从250美元升至280美元
09-03 13:50
Citizens Maintains Market Outperform on Enovis, Lowers Price Target to $47
Citizens analyst David Turkaly maintains Enovis (NYSE:ENOV) with a Market Outperform and lowers the price target from $55 to $47.
09-02 20:50
Enovis to acquire eCential Robotics
Enovis (ENOV) has agreed to acquire eCential Robotics for an upfront enterprise value of €155M. The deal corresponds to cash consideration of approximately €176M to be paid to eCential Robotics’ share...
09-01 19:02
Enovis Enters Into Binding Offer To Acquire eCential Robotics For Upfront Enterprise Value Of €155 Mln
Enhances Enovis’ enabling technology ecosystem to include robotic automation capabilities, empowering surgeons with a broader, integrated set of precision tools in the operating room. Creates a robotics center of excellence in Grenoble, France, a talent rich medical technology hub. Dallas, TX, Sep...
09-01 18:37
Enovis Invests in Innovation with Binding Offer to Acquire eCential Robotics, a Leading Developer of Enabling Technologies and Surgical Robotics
Enovis Corporation has agreed to acquire eCential Robotics for €176 million, enhancing its ASTRA platform with robotic automation to improve surgical precision and efficiency. The deal, expected to close by year-end 2026, will integrate eCential's expertise into Enovis' technology ecosystem, creating a robotics center of excellence in Grenoble, France. Enovis aims to boost patient outcomes and streamline workflows in the operating room through th...
09-01 10:30
美股大行评级 | 潜在涨幅455.56%！Cardiol Therapeutics获Canaccord Genuity上调目标价至10美元，维持"买入"评级
今日重点评级关注：Canaccord Genuity：维持Cardiol Therapeutics"买入"评级，目标价从8美元升至10美元；B. Riley证券：维持Macrogenics"买入"评级，目标价从9美元升至11美元
08-18 11:39
Canaccord Genuity Maintains Buy on Enovis, Lowers Price Target to $45
Canaccord Genuity analyst Caitlin Cronin maintains Enovis (NYSE:ENOV) with a Buy and lowers the price target from $50 to $45.
08-17 20:27
美股大行评级 | 花旗、富国下调闪迪目标价，低至1400美元；百济神州、多邻国、DoorDash、Shopify等获多家机构上调评级
今日重点评级关注：康托·菲茨杰拉德：维持EyePoint"超配"评级，目标价从47美元升至55美元；伯恩斯坦：维持Figure Technology"跑赢大市"评级，目标价从67美元升至70美元
08-07 13:41
BTIG Maintains Buy on Enovis, Raises Price Target to $40
BTIG analyst Ryan Zimmerman maintains Enovis (NYSE:ENOV) with a Buy and raises the price target from $39 to $40.
08-07 02:38
